Life Sciences

Meest recente

1 naar 10 van 432
  • Evidence gathering: Part 1

    Conferentiegesprek

    Ingediend: 02 July 2015

    This session discusses the practicalities of documentary evidence gathering, efficient analysis of that evidence and the expectations of the regulators.

  • New attempts to fight corruption in the German health care sector

    Artikel

    Laatst gecontroleerd: 03 July 2015 / Ingediend: 05 June 2015

    Upcoming legislative changes threatening practices in the German life sciences sector.

  • Episode 0479: Recent pharmaceutical antitrust cases in France

    Video Podcast

    Ingediend: 05 June 2015

    Ombline Ancelin, partner in the Simmons & Simmons Paris office, discusses recent and ongoing competition cases in the pharmaceutical sector in France with Genevieve Borremans, associate in the Brussels office.

  • 统一专利适合谁?

    Artikel

    Laatst gecontroleerd: 02 June 2015 / Ingediend: 02 June 2015

    统一专利即将问世——哪些人适合提出申请?

  • Compliance in Germany - data privacy

    Conferentiegesprek

    Ingediend: 20 May 2015

    This session provided an overview of what data privacy is all about in Germany and the most common pitfalls to be aware of.​

  • Italy prepares to join the Unitary Patent Beperkte toegang

    Artikel

    Ingediend: 15 May 2015

    Italy is preparing to join the Unitary Patent​, having previously expressed scepticism.

  • The Big Bus Company v Ticketogo case update

    Artikel

    Ingediend: 14 May 2015

    Negotiating patent licences – might pre-Action disclosure help?

  • Brevetti e accesso ai farmaci nei Paesi in via di sviluppo

    Artikel

    Ingediend: 11 May 2015

    Il recente accordo tra Gilead e alcune aziende indiane per la produzione su licenza di sofosbuvir e ledipasvir ripropone l’eterna difficoltà di conciliare la tutela della proprietà industriale e la disponibilità di cure a basso costo nei Paesi dov’è maggiore l’emergenza sanitaria. Nel presente articolo, già pubblicato su AboutPharma del mese di marzo 2015, si propongono alcune riflessioni sul tema.

  • The Unitary Patent - who is it for?

    Artikel

    Laatst gecontroleerd: 13 May 2015 / Ingediend: 06 May 2015

    The Unitary Patent is coming - who will choose to have its coverage?​

  • China issues amendment to the Drug Administration Law Beperkte toegang

    Artikel

    Laatst gecontroleerd: 29 April 2015 / Ingediend: 29 April 2015

    China promulgated the Amendment to the Drug Administration Law, which eases the incorporation process for drug companies and removes certain price restrictions.

1 naar 10 van 432